Materialise Nv (MTLS) Stock Analysis

Materialise Nv (MTLS) Financial Summary

Materialise Nv (MTLS) is a Technology company in the Software - Application industry, listed on NASDAQ. The stock currently trades at $5.62 with a market capitalization of $331.96M.

Key valuation metrics include a P/E ratio of 35.28, price-to-book ratio of 1.10, and EPS of $0.15. The company reports a profit margin of 2.8% and return on equity of 3.2%.

MTLS Key Financial Metrics

MTLS Revenue & Earnings History

Materialise Nv (MTLS) Valuation

Based on GoodMoat's DCF model, Materialise Nv has a fair value estimate of $24.67. At the current price of $5.62, the stock appears 77.2% undervalued relative to our intrinsic value estimate.

MTLS Quality Indicators

Materialise Nv maintains a profit margin of 2.8% and an operating margin of 3.3%. Return on equity stands at 3.2%. The current ratio is 2.43. Debt-to-equity ratio is 0.25.

About Materialise Nv

Materialise NV provides additive manufacturing software and 3D printing services in Europe, the Americas, and Asia. The company’s 3D Printing Software segment offers Magics that imports computer-aided design formats and exports standard tessellation language files; Streamics, a central additive manufacturing logistics and control system; 3-maticSTL, a versatile application; MiniMagics and MiniMagicsPro, which provides solutions for customers working in data preparation, or in quoting and quality control teams; build processors and machine control software; and e-Stage that enhances additive manufacturing productivity. This segment serves 3D printing machine original equipment manufacturers; manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company’s Medical segment provides Mimics software for medical image processing; 3-matic that enables to conduct 3D measurements and analyses, design a patient-specific implant or surgical guide, or prepare anatomical data and/or implants for simulations; Mimics Innovation Suite that enables biomedical professionals to perform a multitude of engineering operations; and OrthoView, a 2D digital pre-operative planning and templating solution. It also offers clinical services; and has collaboration agreements with Biomet, Inc., Encore Medical, L.P., DePuy Synthes Companies of Johnson & Johnson, and Zimmer Holdings, Inc. for the development and distribution of surgical planning software, services, and products. This segment serves medical device companies, hospitals, universities, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. The company’s Industrial Production segment primarily offers 3D printing services to industrial and commercial customers. Materialise NV was founded in 1990 and is headquartered in Leuven, Belgium.

MTLS Free Cash Flow

Materialise Nv generated $13.67M in trailing twelve-month free cash flow, representing an FCF yield of 4.12%. This moderate FCF yield indicates reasonable cash generation.

MTLS Shares Outstanding

Materialise Nv has 0.06 billion shares outstanding at a share price of $5.62, giving it a market capitalization of $331.96M.